Division of Nephrology, Department of Medicine, Los Angeles, CA 90033, USA.
Liver Transpl. 2012 May;18(5):539-48. doi: 10.1002/lt.23384.
Acute kidney injury (AKI) at the time of liver transplantation (LT) has been associated with increased morbidity and mortality. In patients with potentially reversible renal dysfunction, predicting whether there will be sufficient return of native kidney function is sometimes difficult. Previous studies have focused mainly on the effect of the severity of renal dysfunction or the duration of pretransplant dialysis on posttransplant outcomes. We performed a retrospective analysis of patients who underwent LT at our center after Model for End-Stage Liver Disease-based allocation so that we could determine the impact of the etiology of AKI [acute tubular necrosis (ATN) versus hepatorenal syndrome (HRS)] on post-LT outcomes. The patients were stratified according to the severity of AKI at the time of LT as described by the Risk, Injury, Failure, Loss, and End-Stage Kidney Disease (RIFLE) classification: risk, injury, or failure. The RIFLE failure group was further subdivided according to the etiology of AKI: HRS or ATN. The patient survival and renal outcomes 1 and 5 years after LT were significantly worse for those with ATN. At 5 years, the incidence of chronic kidney disease (stage 4 or 5) was statistically higher in the ATN group versus the HRS group (56% versus 16%, P < 0.001). A multivariate analysis revealed that the presence of ATN at the time of LT was the only variable associated with higher mortality 1 year after LT (P < 0.001). Our study is the first to demonstrate that the etiology of AKI has the greatest impact on patient and renal outcomes after LT.
肝移植(LT)时的急性肾损伤(AKI)与发病率和死亡率增加有关。在存在潜在可逆转肾功能障碍的患者中,有时难以预测是否会有足够的原生肾功能恢复。以前的研究主要集中在肾功能障碍的严重程度或移植前透析的持续时间对移植后结局的影响上。我们对在我们中心根据终末期肝病模型进行分配后接受 LT 的患者进行了回顾性分析,以便确定 AKI 的病因(急性肾小管坏死(ATN)与肝肾综合征(HRS))对 LT 后结局的影响。根据 RIFLE(风险、损伤、衰竭、损失和终末期肾病)分类描述的 LT 时 AKI 的严重程度对患者进行分层:风险、损伤或衰竭。根据 AKI 的病因,将 RIFLE 衰竭组进一步细分为 HRS 或 ATN。与 ATN 相比,那些患有 ATN 的患者在 LT 后 1 年和 5 年的患者生存率和肾脏结局明显更差。在 5 年时,ATN 组的慢性肾脏病(第 4 或 5 阶段)发生率明显高于 HRS 组(56%比 16%,P < 0.001)。多变量分析显示,LT 时存在 ATN 是 LT 后 1 年死亡率更高的唯一变量(P < 0.001)。我们的研究首次表明,AKI 的病因对 LT 后患者和肾脏结局的影响最大。